Advertisement

Topics

Companies Related to "Lipid Panel Test Market Disease Hyperlipidemia Hypertriglyceridemia Familial" [Most Relevant Company Matches] RSS

01:44 EDT 24th June 2018 | BioPortfolio

Here are the most relevant search results for "Lipid Panel Test Market Disease Hyperlipidemia Hypertriglyceridemia Familial" found in our extensive corporate database of over 50,000 company records.

Showing "Lipid Panel Test Market Disease Hyperlipidemia Hypertriglyceridemia Familial" Companies 1–25 of 6,600+

Relevant

National Lipid Association

The National Lipid Association (NLA) is a multidisciplinary non-profit membership association that serves the community of healthcare professionals who manage patients with lipid disorders and cardiovascular disease. The NLA’s public health mission is to help reduce deaths related to high cholesterol. For more information, please see the NLA Web site ...


BioFire Diagnostics

BioFire Diagnostics, Inc., formerly Idaho Technology, Inc., is a privately held clinical diagnostics company based in Salt Lake City, Utah. The Company manufactures and distributes the FilmArray RP, which operates on the user-friendly FilmArray system, to hospital-based clinical laboratories across the U.S. and EU. With the FilmArray RP, BioFire provides t...

Q-Lab

Q-Panel Lab Products is a global provider of material durability testing products. We produce test substrates, weathering, light stability, corrosion and chip impact testers. Highly qualified independent representatives sell and service Q-Panel’s products in every major market in the world.


VAP Diagnostics Lab

VAP Diagnostics Lab is a new, independent reference laboratory focused solely on the comprehensive VAP®+ Lipid Panel and related cardiometabolic test panels. Using direct (not estimated) measurement, VAP+ identifies cholesterol, triglyceride and genetic lipid disorders, enabling health care professionals to accurately stratify cardiovascular risk and re...

The Foundation of the National Lipid Association

Founded in 2002, the 3,000 members of the National Lipid Association — a nonprofit, multidisciplinary medical society focused on enhancing the practice of lipid management in clinical medicine — share a common goal: to enhance the practice of lipid management in clinical medicine and to reduce the morbidity and mortality associated with atherosclerotic ...

BioFire Diagnostics, Inc.

BioFire Diagnostics, Inc., formerly Idaho Technology, Inc., is a privately held clinical diagnostics company based in Salt Lake City, Utah. The company manufactures and distributes the user friendly FilmArray System to hospital-based clinical laboratories across the U.S. and EU. BioFire currently offers the FDA-cleared and CE IVD marked FilmArray Respirato...

BioFire Diagnostics, LLC

BioFire Diagnostics, LLC, a wholly owned subsidiary of bioMérieux, Inc., manufactures and distributes the user-friendly FilmArray System to hospital-based clinical laboratories throughout the world. BioFire currently offers the FDA-cleared and CE IVD marked FilmArray Respiratory Panel, Blood Culture Identification Panel and Gastrointestinal Panel. The c...

Polymer Technology Systems, Inc.

Polymer Technology Systems, Inc. (PTS, Inc.) is a global provider of point-of-care diagnostic products to the healthcare industry. Headquartered in Indianapolis, Indiana, PTS, Inc. manufactures products for distribution in 100 countries around the world. The company has sales offices in Africa, Australia, Europe, Latin America, the Middle East and the Paci...

GenMark Diagnostics Inc.

GenMark Diagnostics is a leading provider of automated, multiplex molecular diagnostic testing systems that detect and measure DNA and RNA targets to diagnose disease and optimize patient treatment. Utilizing GenMark’s proprietary eSensor® detection technology, GenMark's eSensor® XT-8 system is designed to support a broad range of molecular diagnostic ...

Panel Intelligence

Panel Intelligence, LLC, based in Cambridge, Mass., provides primary market research to corporate and financial clients in the healthcare industry. Its seasoned research staff understands the unique complexities of each industry, as well as the types of decisions our clients need to support. It works closely with its clients to identify objectives, recruit experts, elicit information, and synthesi...

Boston Heart Lab

Boston Heart Lab enables cardiologists and other clinicians to prescribe personalized treatment plans for cardiovascular disease and lipid disorders that offer patients the best opportunity for improved health outcomes, based on a panel of tests that provides the most comprehensive assessment available detailing the cause and state of the patient's disease. The company's proprietary two-dimensiona...

Lipid Sciences

Lipid Sciences, Inc. (LIPD) is a development-stage biotechnology company that is researching and developing products and processes to treat major medical indications such as cardiovascular disease, HIV and other viral infections in which lipids or fat components play a key role. LIPD's technologies are based on a patented process that selectively and rapidly removes lipids from proteins circulatin...

Interleukin Genetics, Inc.

Interleukin Genetics, Inc. (OTCQB: ILIU) develops and markets proprietary genetic tests for chronic diseases and health related conditions. The products empower individuals to prevent certain chronic conditions and manage their existing health and wellness through genetic-based insights with actionable guidance. Interleukin Genetics leverages its resear...

Interleukin Genetics, Inc.

Interleukin Genetics, Inc. (OTCQB: ILIU) develops and markets a line of genetic tests under the Inherent Health® brand. The products empower individuals to prevent certain chronic conditions and manage their existing health and wellness through genetic-based insights with actionable guidance. Interleukin Genetics leverages its research, intell...

King-Devick Test, Inc.

King-Devick Test is used worldwide as a proven indicator of saccadic eye movements as they relate to reading, using Rapid Number Naming. Elite neurological journals have called the King-Devick Test an "accurate and reliable method for identifying athletes with head trauma." Other studies have proven King-Devick Test to help determine neurological functiona...

Amarin Corporation plc

Amarin is a clinical-stage biopharmaceutical company with a focus on cardiovascular disease. The Company’s lead product candidate is AMR101(ethyl icosapentate), which is entering Phase 3 clinical trials for the treatment of very high triglycerides and high triglycerides in patients with mixed dyslipidemia, under Special Protocol Assessment agreements ...

Chronix Biomedical, Inc

Chronix Biomedical is a functional genomics company whose products address the chronic disease markets both human and veterinary. The company's product line is based on its proprietary approach to developing laboratory tests for the detection and monitoring of a new class of markers for chronic illnesses: circulating nucleic acids (CNA). Chronix's is seeking to validate its first two tests. The f...

D-Pharm Business Development Unit US

Established in April 1993 by Dr. Alex Kozak, D-Pharm is a specialty pharmaceutical company that designs and develops innovative drugs for the treatment of the most devastating brain disorders. The Company has developed two unique platform technologies that generate lipid–like medicines which utilise lipid specific mechanisms and lipid-related pathways in living cells. The Company’s drug candi...

Atherotech, Inc.

Atherotech is a CLIA-certified clinical reference laboratory and cardiodiagnostic company focusing on cardiometabolic tests, including the company's patented VAP Cholesterol Test, which reports the cholesterol content of all lipids, components and subclasses. The VAP Test is the first cholesterol profile to comply with updated National Cholesterol Education Program ATP III recommendations for dire...

Prevencio, Inc.

Prevencio, a development stage company, is pioneering multiplex proteomic cardiac biomarker diagnostic tests for ruling out obstructive coronary artery disease in chest pain patients in the emergency room. The Company's proprietary HART™ Test will be a first-in-class product. The worldwide market potential for the HART™ Test is estimated to be $2 ...

Avitar Incorporated

Avitar, Inc. (AMEX:AVR) develops, manufactures and markets innovative and proprietary products in the oral fluid diagnostic market, disease and clinical testing market, and customized polyurethane applications used in the wound dressing industry. Oral fluid diagnostics includes the estimated $1.5 billion drugs-of-abuse testing market, which encompasses the corporate workplace and criminal justice ...

AltheaDx, Inc.

AltheaDx is a commercial stage molecular diagnostics company which focuses on enabling physicians, managed care organizations, pharmaceutical companies and other healthcare entities to make personalized therapeutic decisions for patients. AltheaDx’s Research Services’ NGS portfolio includes pre-qualified panels such as AOP™150, Cancer Hotspo...

Sancilio Pharmaceuticals Company, Inc.

Sancilio Pharmaceuticals Company, Inc. (SPCI) is a fully integrated, specialty pharmaceutical company focused on developing, manufacturing and commercializing pharmaceutical products, including those based on our proprietary Advanced Lipid Technologies™ (ALT™) platform. SPCI is pursuing treatments for sickle cell disease, short bowel syndrome and ...

Marker Test Diagnostics

Founded in 2013, Marker Test Diagnostics is the producer of UR Code (TM), an innovative oral marker for the drug testing market. Marker Test Diagnostics is currently conducting research studies in the field of addiction and sport and collaborates with the Olympic Doping Laboratory at the UCLA and a renowned research university. For more information about M...

Aegerion Pharmaceuticals, Inc.

Aegerion Pharmaceuticals is a biopharmaceutical company dedicated to the development and commercialization of innovative, life-altering therapies for patients with debilitating often fatal, rare diseases. Therapeutic focus Homozygous familial hypercholesterolemia (HoFH) is the most severe form of familial hypercholesterolemia. HoFH is caused by genetic defects inherited from both parents tha...


More From BioPortfolio on "Lipid Panel Test Market Disease Hyperlipidemia Hypertriglyceridemia Familial"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks